3FQ9
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Rubredoxin, Soluble cytochrome b562, Melatonin receptor type 1B - Escherichia coli, Homo sapiens, Clostridium pasteurianum
LOADING 86%